The Recall Desk

FDA (Drugs) recall action 75289

Wells Pharmacy Network LLC recalled 97 products on 2017-01-11

The FDA (Drugs) publishes a recall like this one as 97 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 97 pages.

Products
97
Announced
2017-01-11
Critical
0
Units
43,614

Why these products were recalled

Lack of Assurance of Sterility

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

51–75 of 97

  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Injectable Compounds Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 147 vials of a compounded injectable drug due to a lack of assurance of sterility. The products were distributed nationwide.

    Product
    Glutamine/ORNI/Arginine/LYS/CITRU+LIDO 75 mg/75 mg/150 mg/50 mg/100 mg/10 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls QUAD4 Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling QUAD4 injectable vials because the FDA determined there is a lack of assurance of sterility.

    Product
    QUAD4 (PAP/PHEN/ALPROS/ATRO) 30 mg/3 mg/60 mcg/0.2 mg/mL Injectable, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    FDA Recalls Compounded Injectable Due to Lack of Sterility Assurance

    Wells Pharmacy Network is recalling Arginine/Citrulline/Ornit+Lido injectable vials due to a lack of assurance of sterility.

    Product
    Arginine/Citrulline/Ornit+Lido 100/100/100/10 mg/mL Injectable, 10 mL vials, Compounded by Wells Pharmacy Network, LLC, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Trimix Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling Trimix Injectable vials because the product may lack assurance of sterility.

    Product
    Trimix Injectable 17.65 mg/0.59 mg/5.9 mcg/mL a) 2 mL, b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Methylcobalamin Injectable Kits Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling Methylcobalamin Injectable kits due to a lack of assurance of sterility. The recall covers kits prepared between February 2016 and September 2016.

    Product
    Methylcobalamin Injectable (Dr. Hall Kit) - 1,000 mcg/mL, 30 mL vial Kit, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Trimix Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling specific vials of Trimix Injectable because the agency could not ensure the product was sterile.

    Product
    Trimix Injectable 30 mg/3 mg/60 mcg/mL, a) 2 mL, b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Testosterone Enanthate Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 1,250 vials of compounded Testosterone Enanthate Injectable nationwide due to a lack of assurance of sterility.

    Product
    Testosterone Enanthate in Grapeseed Oil Injectable, 200 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Testosterone Cypionate Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 203 vials of compounded Testosterone Cypionate/Anastrozole Injectable nationwide due to a lack of assurance of sterility.

    Product
    Testosterone Cypionate/Anastrozole Injectable, 200 mg/1 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    FDA Recalls Tri 1 Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling Tri 1 (PAP/PHEN/ATROPINE) NR Injectable vials because the product lacks assurance of sterility.

    Product
    Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Injectable Compounds Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 933 vials of MIC/B-COMP/(M)/CHROM/CARN Injectable due to a lack of assurance of sterility.

    Product
    MIC/B-COMP/(M)/CHROM/CARN, 20 mg/40 mg/50 mg/25 mcg/25 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Trimix Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling Trimix Injectable vials because the agency could not ensure the product was sterile. The recall covers vials prepared between February 2016 and September 2016.

    Product
    Trimix Injectable 30 mg/1 mg/10 mcg/mL a) 2 mL and b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    FDA Recalls Sermorelin Acetate Injectable Kits Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP (2) Injectable Kits nationwide due to a lack of assurance of sterility.

    Product
    Sermorelin Acetate/GHRP (2) Kit 6 mg/4.5 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Injectable Compounded Drug Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 22 vials of a compounded injectable drug due to a lack of assurance of sterility.

    Product
    Forskolin/PAPAV/PHEN/PGE1, 100 mcg/30 mcg/3 mcg/60 mcg/mL, 5 mL vial, Injectable, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    FDA Recalls Sermorelin Acetate Injectable Kits Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP Injectable Kits nationwide due to a lack of assurance of sterility.

    Product
    Sermorelin Acetate/GHRP (2) & (6) 9 mg/9 mg/9 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Carnitine-L Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 44 vials of Carnitine-L 250 mg/mL Injectable due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    Carnitine-L 250 mg/mL Injectable, 30 mL vials, Rx only, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Leucine/Isoleucine/Valine Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 189 vials of Leucine/Isoleucine/Valine Injectable due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    Leucine/Isoleucine/Valine 10 mg/10 mg/5 mg/5 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Methylcobalamin Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 265 vials of compounded Methylcobalamin 5,000 mcg/mL Injectable because the product lacks assurance of sterility.

    Product
    Methylcobalamin 5,000 mcg/mL Injectable, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Trimix with Atropine Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling specific lots of Trimix with Atropine Injectable because the agency could not ensure the product was sterile.

    Product
    Trimix with Atropine Injectable 30 mg/3 mg/150 mcg/0.2 mg/mL, a) 2 mL b) 5 mL and 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    FDA Recalls Sermorelin Injectable Kits Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP Injectable Kits nationwide because the agency cannot assure the product is sterile.

    Product
    Sermorelin Acetate/GHRP (2) & (6) 9 mg/3.15 mg/3.15 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Phenylephrine HCl Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling 1,968 vials of Phenylephrine HCl Injectable due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    Phenylephrine HCl Injectable, 1 mg/mL (0.1%), 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2017-01-11

    Wells Pharmacy Recalls Trimix with Atropine Injectable Due to Sterility Concerns

    Wells Pharmacy Network LLC is recalling Trimix with Atropine Injectable vials due to a lack of assurance of sterility. The recall covers products prepared between February 2016 and September 2016.

    Product
    Trimix with Atropine Injectable 30 mg/3 mg/60 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
    Category
    Distribution
    0 states